Moderna, BioNTech Lead Covid Sell-Off After Pfizer Slashes Its Outlook By $9 BillionInvestors Business Daily • 10/16/23
Vaccine Stocks—Including Pfizer, Moderna, BioNTech And Novavax—Slide Amid Plummeting DemandForbes • 10/16/23
BioNTech's stock sinks after disclosing expected charge of up to nearly $1 billion resulting from Pfizer's write offs of COVID productsMarket Watch • 10/16/23
Pfizer shares fall on guidance cut, weighing on BioNTech and Moderna stocks, and other shares on the moveMarket Watch • 10/16/23